| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Neoplasms | 34 | 2025 | 1262 | 2.760 |
Why?
|
| Health Knowledge, Attitudes, Practice | 34 | 2022 | 743 | 2.530 |
Why?
|
| Health Surveys | 25 | 2025 | 311 | 1.610 |
Why?
|
| Internet | 13 | 2019 | 465 | 1.270 |
Why?
|
| United States | 74 | 2025 | 7622 | 1.180 |
Why?
|
| Adult | 96 | 2025 | 15972 | 1.140 |
Why?
|
| Cooperative Behavior | 10 | 2012 | 220 | 1.090 |
Why?
|
| Attitude to Death | 3 | 2013 | 17 | 1.040 |
Why?
|
| Health Behavior | 18 | 2020 | 472 | 1.040 |
Why?
|
| Health Care Surveys | 10 | 2022 | 281 | 1.020 |
Why?
|
| Humans | 174 | 2025 | 60081 | 1.010 |
Why?
|
| Patient-Centered Care | 4 | 2022 | 250 | 0.990 |
Why?
|
| Communication | 7 | 2022 | 558 | 0.990 |
Why?
|
| Adolescent | 60 | 2025 | 5944 | 0.960 |
Why?
|
| Middle Aged | 78 | 2025 | 16542 | 0.950 |
Why?
|
| Bone Neoplasms | 16 | 1994 | 117 | 0.950 |
Why?
|
| Vegetables | 9 | 2015 | 91 | 0.930 |
Why?
|
| Surveys and Questionnaires | 31 | 2025 | 2615 | 0.920 |
Why?
|
| Fruit | 9 | 2015 | 124 | 0.920 |
Why?
|
| Young Adult | 38 | 2025 | 4398 | 0.920 |
Why?
|
| Retirement | 1 | 2024 | 17 | 0.910 |
Why?
|
| Male | 102 | 2025 | 27951 | 0.870 |
Why?
|
| Information Seeking Behavior | 8 | 2025 | 36 | 0.840 |
Why?
|
| Female | 104 | 2025 | 31226 | 0.830 |
Why?
|
| Athletes | 1 | 2024 | 97 | 0.820 |
Why?
|
| Physician-Patient Relations | 4 | 2021 | 395 | 0.800 |
Why?
|
| Attitude to Health | 9 | 2013 | 280 | 0.750 |
Why?
|
| Patient Acceptance of Health Care | 7 | 2013 | 455 | 0.730 |
Why?
|
| National Cancer Institute (U.S.) | 12 | 2024 | 34 | 0.730 |
Why?
|
| Health Services Accessibility | 9 | 2019 | 546 | 0.730 |
Why?
|
| Sexual and Gender Minorities | 2 | 2020 | 72 | 0.730 |
Why?
|
| Public Opinion | 1 | 2020 | 22 | 0.720 |
Why?
|
| Information Services | 5 | 2016 | 34 | 0.700 |
Why?
|
| Prostatic Neoplasms | 4 | 2020 | 330 | 0.680 |
Why?
|
| Quality of Life | 7 | 2019 | 1140 | 0.670 |
Why?
|
| Interdisciplinary Communication | 6 | 2012 | 108 | 0.670 |
Why?
|
| Neurosurgery | 4 | 2024 | 30 | 0.660 |
Why?
|
| Aged | 57 | 2025 | 13596 | 0.660 |
Why?
|
| Emigrants and Immigrants | 1 | 2020 | 36 | 0.650 |
Why?
|
| Religion and Medicine | 2 | 2019 | 22 | 0.650 |
Why?
|
| Perception | 5 | 2020 | 179 | 0.640 |
Why?
|
| Cross-Sectional Studies | 23 | 2025 | 2507 | 0.630 |
Why?
|
| Papillomaviridae | 1 | 2019 | 60 | 0.620 |
Why?
|
| Breast Neoplasms | 6 | 2015 | 1132 | 0.620 |
Why?
|
| Group Processes | 5 | 2008 | 41 | 0.610 |
Why?
|
| Smoking | 12 | 2016 | 837 | 0.600 |
Why?
|
| Mass Screening | 8 | 2020 | 662 | 0.600 |
Why?
|
| Patient Participation | 1 | 2020 | 214 | 0.590 |
Why?
|
| Papillomavirus Vaccines | 1 | 2019 | 72 | 0.580 |
Why?
|
| Tobacco Use | 1 | 2018 | 37 | 0.580 |
Why?
|
| Feeding Behavior | 5 | 2015 | 315 | 0.560 |
Why?
|
| Schools | 5 | 2022 | 155 | 0.560 |
Why?
|
| Papillomavirus Infections | 1 | 2019 | 127 | 0.560 |
Why?
|
| Sexual Behavior | 2 | 2018 | 185 | 0.530 |
Why?
|
| Research Personnel | 5 | 2008 | 86 | 0.520 |
Why?
|
| Uterine Cervical Neoplasms | 2 | 2015 | 146 | 0.510 |
Why?
|
| Consumer Health Information | 6 | 2025 | 35 | 0.510 |
Why?
|
| Abdominal Pain | 1 | 2016 | 94 | 0.510 |
Why?
|
| Healthy People Programs | 4 | 2020 | 11 | 0.500 |
Why?
|
| Medical Informatics | 6 | 2019 | 68 | 0.500 |
Why?
|
| Brain Neoplasms | 4 | 2015 | 306 | 0.500 |
Why?
|
| Health Status | 7 | 2014 | 451 | 0.490 |
Why?
|
| Prostate-Specific Antigen | 2 | 2020 | 67 | 0.490 |
Why?
|
| Health Communication | 6 | 2019 | 33 | 0.480 |
Why?
|
| Neurosurgical Procedures | 2 | 2024 | 94 | 0.480 |
Why?
|
| Heart Diseases | 2 | 2014 | 206 | 0.470 |
Why?
|
| Goals | 4 | 2020 | 91 | 0.470 |
Why?
|
| Weight Loss | 1 | 2016 | 264 | 0.450 |
Why?
|
| Socioeconomic Factors | 18 | 2017 | 792 | 0.440 |
Why?
|
| Soft Tissue Neoplasms | 9 | 1995 | 31 | 0.430 |
Why?
|
| Huntingtin Protein | 3 | 2019 | 138 | 0.430 |
Why?
|
| Early Detection of Cancer | 6 | 2020 | 272 | 0.420 |
Why?
|
| Research | 2 | 2012 | 190 | 0.420 |
Why?
|
| Colorectal Neoplasms | 2 | 2015 | 263 | 0.410 |
Why?
|
| Age Factors | 12 | 2020 | 1527 | 0.400 |
Why?
|
| Acculturation | 4 | 2015 | 48 | 0.400 |
Why?
|
| Biomedical Research | 4 | 2016 | 253 | 0.400 |
Why?
|
| Motor Activity | 5 | 2014 | 343 | 0.400 |
Why?
|
| Databases, Factual | 3 | 2016 | 850 | 0.400 |
Why?
|
| Diabetes Mellitus | 2 | 2014 | 538 | 0.390 |
Why?
|
| Cancer Survivors | 2 | 2024 | 80 | 0.380 |
Why?
|
| Osteosarcoma | 6 | 1994 | 53 | 0.370 |
Why?
|
| Information Dissemination | 4 | 2016 | 119 | 0.370 |
Why?
|
| Sex Factors | 9 | 2018 | 971 | 0.360 |
Why?
|
| Diet | 8 | 2022 | 638 | 0.360 |
Why?
|
| Magnetic Resonance Imaging | 21 | 2015 | 2049 | 0.350 |
Why?
|
| Nutrition Surveys | 8 | 2016 | 153 | 0.340 |
Why?
|
| Radiotherapy, Intensity-Modulated | 1 | 2010 | 34 | 0.330 |
Why?
|
| Nutrition Policy | 4 | 2014 | 49 | 0.330 |
Why?
|
| Radiotherapy Planning, Computer-Assisted | 1 | 2010 | 56 | 0.330 |
Why?
|
| Radiosurgery | 1 | 2010 | 61 | 0.320 |
Why?
|
| Prevalence | 6 | 2018 | 1299 | 0.320 |
Why?
|
| Neoplasms, Multiple Primary | 6 | 1993 | 29 | 0.320 |
Why?
|
| Therapy, Computer-Assisted | 1 | 2008 | 24 | 0.310 |
Why?
|
| Logistic Models | 10 | 2022 | 1262 | 0.300 |
Why?
|
| Survivors | 3 | 2016 | 148 | 0.300 |
Why?
|
| Electronic Health Records | 3 | 2017 | 354 | 0.300 |
Why?
|
| Hypertension | 1 | 2014 | 603 | 0.300 |
Why?
|
| Psychometrics | 3 | 2025 | 359 | 0.300 |
Why?
|
| Mass Media | 4 | 2013 | 31 | 0.290 |
Why?
|
| User-Computer Interface | 1 | 2008 | 131 | 0.290 |
Why?
|
| Cognition | 1 | 2012 | 466 | 0.290 |
Why?
|
| Diet Surveys | 5 | 2011 | 78 | 0.290 |
Why?
|
| Food Preferences | 3 | 2013 | 55 | 0.290 |
Why?
|
| Global Health | 3 | 2024 | 165 | 0.290 |
Why?
|
| Health Promotion | 7 | 2012 | 490 | 0.280 |
Why?
|
| Reproducibility of Results | 7 | 2025 | 1565 | 0.280 |
Why?
|
| Trust | 4 | 2020 | 69 | 0.280 |
Why?
|
| Ovarian Neoplasms | 2 | 2019 | 138 | 0.280 |
Why?
|
| Data Collection | 7 | 2020 | 383 | 0.270 |
Why?
|
| Meningeal Neoplasms | 3 | 2015 | 57 | 0.260 |
Why?
|
| Meningioma | 3 | 2015 | 58 | 0.260 |
Why?
|
| Exercise | 6 | 2022 | 919 | 0.260 |
Why?
|
| Patient Satisfaction | 4 | 2015 | 419 | 0.260 |
Why?
|
| Multiple Chronic Conditions | 2 | 2017 | 37 | 0.260 |
Why?
|
| Social Support | 4 | 2015 | 366 | 0.240 |
Why?
|
| Smoking Cessation | 3 | 2013 | 538 | 0.240 |
Why?
|
| Personal Satisfaction | 2 | 2024 | 78 | 0.240 |
Why?
|
| Genetic Therapy | 4 | 2022 | 742 | 0.230 |
Why?
|
| Tomography, X-Ray Computed | 14 | 2016 | 1481 | 0.230 |
Why?
|
| RNA, Small Interfering | 2 | 2021 | 855 | 0.230 |
Why?
|
| Body Mass Index | 4 | 2017 | 892 | 0.230 |
Why?
|
| Pediatric Obesity | 2 | 2017 | 99 | 0.230 |
Why?
|
| Alcohol Drinking | 3 | 2022 | 305 | 0.230 |
Why?
|
| Vocabulary, Controlled | 2 | 2016 | 11 | 0.230 |
Why?
|
| Colonic Neoplasms | 4 | 2009 | 216 | 0.230 |
Why?
|
| Food Services | 2 | 2014 | 29 | 0.220 |
Why?
|
| Huntington Disease | 2 | 2018 | 146 | 0.220 |
Why?
|
| Lung Neoplasms | 7 | 2013 | 579 | 0.220 |
Why?
|
| Micronutrients | 1 | 2024 | 29 | 0.220 |
Why?
|
| Spinal Dysraphism | 1 | 2024 | 16 | 0.220 |
Why?
|
| Educational Status | 7 | 2017 | 273 | 0.220 |
Why?
|
| Professional-Patient Relations | 3 | 2016 | 128 | 0.220 |
Why?
|
| Fanconi Anemia | 2 | 2013 | 15 | 0.220 |
Why?
|
| Family | 3 | 2013 | 224 | 0.210 |
Why?
|
| Giant Cell Tumors | 3 | 1992 | 5 | 0.210 |
Why?
|
| Food Supply | 2 | 2015 | 74 | 0.210 |
Why?
|
| Sibling Relations | 1 | 2002 | 5 | 0.210 |
Why?
|
| Bias | 3 | 2022 | 106 | 0.210 |
Why?
|
| Child | 17 | 2022 | 4313 | 0.200 |
Why?
|
| Factor Analysis, Statistical | 1 | 2022 | 105 | 0.200 |
Why?
|
| Physicians, Family | 3 | 1991 | 75 | 0.200 |
Why?
|
| Tibia | 4 | 1992 | 70 | 0.200 |
Why?
|
| Parent-Child Relations | 1 | 2002 | 63 | 0.200 |
Why?
|
| Behavioral Research | 1 | 2022 | 15 | 0.200 |
Why?
|
| Radiography | 12 | 2010 | 514 | 0.190 |
Why?
|
| Motivation | 1 | 2024 | 270 | 0.190 |
Why?
|
| Diagnosis, Differential | 8 | 2016 | 908 | 0.190 |
Why?
|
| Tay-Sachs Disease | 1 | 2022 | 34 | 0.190 |
Why?
|
| Developing Countries | 2 | 2024 | 85 | 0.190 |
Why?
|
| Self Efficacy | 4 | 2016 | 199 | 0.190 |
Why?
|
| Guideline Adherence | 3 | 2014 | 298 | 0.190 |
Why?
|
| Beverages | 3 | 2017 | 65 | 0.190 |
Why?
|
| Parents | 3 | 2013 | 389 | 0.190 |
Why?
|
| Biological Warfare | 1 | 2001 | 3 | 0.190 |
Why?
|
| Bioterrorism | 1 | 2001 | 11 | 0.190 |
Why?
|
| Neostriatum | 2 | 2018 | 25 | 0.190 |
Why?
|
| Risk Assessment | 6 | 2015 | 1936 | 0.180 |
Why?
|
| Risk | 3 | 2017 | 376 | 0.180 |
Why?
|
| Models, Organizational | 4 | 2008 | 93 | 0.180 |
Why?
|
| Science | 4 | 2008 | 34 | 0.180 |
Why?
|
| Glioblastoma | 3 | 2015 | 156 | 0.180 |
Why?
|
| National Institutes of Health (U.S.) | 4 | 2016 | 113 | 0.180 |
Why?
|
| Dependovirus | 5 | 2022 | 659 | 0.180 |
Why?
|
| Disaster Planning | 1 | 2001 | 51 | 0.180 |
Why?
|
| Dacarbazine | 2 | 2010 | 20 | 0.180 |
Why?
|
| Decision Making | 3 | 2013 | 394 | 0.180 |
Why?
|
| Health Records, Personal | 2 | 2017 | 26 | 0.170 |
Why?
|
| Self Report | 2 | 2014 | 369 | 0.170 |
Why?
|
| California | 4 | 2014 | 161 | 0.170 |
Why?
|
| Uncertainty | 2 | 2013 | 33 | 0.170 |
Why?
|
| Salpingo-oophorectomy | 1 | 2019 | 3 | 0.170 |
Why?
|
| Registries | 4 | 2024 | 811 | 0.170 |
Why?
|
| Genetic Predisposition to Disease | 3 | 2017 | 677 | 0.170 |
Why?
|
| Military Personnel | 1 | 2001 | 97 | 0.170 |
Why?
|
| Students | 1 | 2022 | 208 | 0.170 |
Why?
|
| Consumer Behavior | 2 | 2010 | 35 | 0.170 |
Why?
|
| Telemedicine | 2 | 2020 | 337 | 0.170 |
Why?
|
| Multivariate Analysis | 6 | 2017 | 928 | 0.170 |
Why?
|
| Hemangioma | 5 | 1994 | 28 | 0.170 |
Why?
|
| Aged, 80 and over | 11 | 2019 | 5200 | 0.170 |
Why?
|
| Risk Factors | 11 | 2015 | 5090 | 0.160 |
Why?
|
| Vulnerable Populations | 1 | 2020 | 87 | 0.160 |
Why?
|
| Access to Information | 2 | 2016 | 30 | 0.160 |
Why?
|
| Fibroma | 4 | 1991 | 12 | 0.160 |
Why?
|
| Delivery of Health Care | 3 | 2022 | 424 | 0.160 |
Why?
|
| Choice Behavior | 2 | 2017 | 77 | 0.150 |
Why?
|
| Muscular Diseases | 3 | 1994 | 47 | 0.150 |
Why?
|
| Time-to-Treatment | 1 | 2019 | 100 | 0.150 |
Why?
|
| Quality of Health Care | 2 | 2015 | 524 | 0.150 |
Why?
|
| Bolivia | 2 | 2017 | 2 | 0.150 |
Why?
|
| Obesity | 5 | 2014 | 1191 | 0.150 |
Why?
|
| Putamen | 1 | 2018 | 19 | 0.150 |
Why?
|
| Caudate Nucleus | 1 | 2018 | 25 | 0.150 |
Why?
|
| Femoral Neoplasms | 3 | 1992 | 5 | 0.150 |
Why?
|
| Carbonated Beverages | 2 | 2017 | 20 | 0.150 |
Why?
|
| Mutant Proteins | 1 | 2018 | 105 | 0.140 |
Why?
|
| Biomarkers | 2 | 2014 | 1214 | 0.140 |
Why?
|
| Pancreatic Neoplasms | 2 | 1992 | 328 | 0.140 |
Why?
|
| Sheep | 4 | 2021 | 168 | 0.140 |
Why?
|
| Sweetening Agents | 1 | 2017 | 25 | 0.140 |
Why?
|
| Central Nervous System | 1 | 2019 | 192 | 0.140 |
Why?
|
| Skin Neoplasms | 4 | 2009 | 405 | 0.140 |
Why?
|
| Prophylactic Surgical Procedures | 1 | 2017 | 2 | 0.140 |
Why?
|
| Internationality | 1 | 2017 | 42 | 0.140 |
Why?
|
| Salpingectomy | 1 | 2017 | 5 | 0.140 |
Why?
|
| Anesthesia | 1 | 2017 | 52 | 0.140 |
Why?
|
| Genes, BRCA1 | 1 | 2017 | 19 | 0.140 |
Why?
|
| Genes, BRCA2 | 1 | 2017 | 14 | 0.140 |
Why?
|
| Ovariectomy | 1 | 2017 | 97 | 0.140 |
Why?
|
| Virus Internalization | 1 | 2018 | 99 | 0.140 |
Why?
|
| Patient Education as Topic | 2 | 2019 | 450 | 0.140 |
Why?
|
| Wireless Technology | 1 | 2016 | 18 | 0.140 |
Why?
|
| Medical Informatics Computing | 1 | 2016 | 1 | 0.140 |
Why?
|
| Survival Rate | 2 | 2016 | 793 | 0.130 |
Why?
|
| Common Data Elements | 1 | 2016 | 5 | 0.130 |
Why?
|
| Life Style | 3 | 2014 | 330 | 0.130 |
Why?
|
| Obstetrics | 1 | 2017 | 87 | 0.130 |
Why?
|
| Caregivers | 2 | 2012 | 232 | 0.130 |
Why?
|
| Physicians | 1 | 2021 | 442 | 0.130 |
Why?
|
| Health Education | 4 | 2013 | 184 | 0.130 |
Why?
|
| Surgical Procedures, Operative | 1 | 2017 | 139 | 0.130 |
Why?
|
| Hand Strength | 1 | 2016 | 29 | 0.130 |
Why?
|
| Odds Ratio | 7 | 2011 | 774 | 0.130 |
Why?
|
| Urban Population | 1 | 2017 | 185 | 0.130 |
Why?
|
| Smoking Prevention | 4 | 2013 | 162 | 0.130 |
Why?
|
| Physical Fitness | 1 | 2016 | 92 | 0.130 |
Why?
|
| Convection | 2 | 2013 | 10 | 0.120 |
Why?
|
| Longitudinal Studies | 2 | 2018 | 1239 | 0.120 |
Why?
|
| Contrast Media | 3 | 2015 | 414 | 0.120 |
Why?
|
| Neurons | 2 | 2018 | 861 | 0.120 |
Why?
|
| Chondrosarcoma | 2 | 1994 | 6 | 0.120 |
Why?
|
| Demeclocycline | 1 | 2015 | 4 | 0.120 |
Why?
|
| Thigh | 7 | 1994 | 25 | 0.120 |
Why?
|
| Tobacco Use Disorder | 2 | 2008 | 245 | 0.120 |
Why?
|
| Time Factors | 6 | 2013 | 3621 | 0.120 |
Why?
|
| Public Health | 2 | 2014 | 180 | 0.120 |
Why?
|
| Interviews as Topic | 6 | 2014 | 495 | 0.120 |
Why?
|
| Rural Population | 1 | 2017 | 193 | 0.120 |
Why?
|
| Legislation, Food | 1 | 2014 | 3 | 0.120 |
Why?
|
| Recommended Dietary Allowances | 1 | 2014 | 11 | 0.120 |
Why?
|
| Wounds and Injuries | 1 | 2017 | 243 | 0.120 |
Why?
|
| Osteoma, Osteoid | 2 | 1991 | 3 | 0.120 |
Why?
|
| Child, Preschool | 10 | 2015 | 1839 | 0.120 |
Why?
|
| Ischium | 1 | 1994 | 3 | 0.120 |
Why?
|
| Food Dispensers, Automatic | 2 | 2013 | 2 | 0.120 |
Why?
|
| Genetic Vectors | 3 | 2018 | 818 | 0.120 |
Why?
|
| Chronic Disease | 2 | 2017 | 744 | 0.110 |
Why?
|
| Microscopy, Confocal | 1 | 2015 | 221 | 0.110 |
Why?
|
| Education, Medical, Graduate | 1 | 2017 | 319 | 0.110 |
Why?
|
| Ki-67 Antigen | 1 | 2014 | 34 | 0.110 |
Why?
|
| Computational Biology | 1 | 2016 | 337 | 0.110 |
Why?
|
| Resistance Training | 1 | 2014 | 20 | 0.110 |
Why?
|
| Eating | 1 | 2015 | 139 | 0.110 |
Why?
|
| Taxes | 1 | 2013 | 6 | 0.110 |
Why?
|
| Behavioral Sciences | 1 | 2013 | 2 | 0.110 |
Why?
|
| Accelerometry | 1 | 2014 | 59 | 0.110 |
Why?
|
| Primary Prevention | 2 | 2013 | 137 | 0.110 |
Why?
|
| Famous Persons | 1 | 2013 | 8 | 0.110 |
Why?
|
| Anxiety | 3 | 2008 | 400 | 0.110 |
Why?
|
| Quality-Adjusted Life Years | 1 | 2014 | 61 | 0.110 |
Why?
|
| Antineoplastic Agents, Alkylating | 2 | 2010 | 31 | 0.110 |
Why?
|
| Models, Economic | 1 | 2013 | 42 | 0.110 |
Why?
|
| Glioma | 2 | 2015 | 102 | 0.110 |
Why?
|
| Disease Models, Animal | 3 | 2018 | 2074 | 0.110 |
Why?
|
| Stem Cell Transplantation | 1 | 2013 | 74 | 0.110 |
Why?
|
| Guidelines as Topic | 1 | 2014 | 158 | 0.110 |
Why?
|
| Sarcoma, Ewing | 1 | 1993 | 11 | 0.110 |
Why?
|
| Mathematics | 1 | 2012 | 28 | 0.100 |
Why?
|
| Papanicolaou Test | 2 | 2009 | 41 | 0.100 |
Why?
|
| Vaginal Smears | 2 | 2009 | 53 | 0.100 |
Why?
|
| Information Storage and Retrieval | 2 | 2013 | 80 | 0.100 |
Why?
|
| Community Participation | 2 | 2012 | 44 | 0.100 |
Why?
|
| Gene Expression Regulation | 1 | 2019 | 1542 | 0.100 |
Why?
|
| Cost-Benefit Analysis | 1 | 2014 | 302 | 0.100 |
Why?
|
| Meaningful Use | 1 | 2012 | 8 | 0.100 |
Why?
|
| Physical Education and Training | 1 | 2012 | 31 | 0.100 |
Why?
|
| Corpus Striatum | 1 | 2013 | 93 | 0.100 |
Why?
|
| Financing, Organized | 1 | 2012 | 16 | 0.100 |
Why?
|
| Coffee | 1 | 1992 | 19 | 0.100 |
Why?
|
| Neuronavigation | 1 | 2011 | 13 | 0.100 |
Why?
|
| Community Networks | 2 | 2008 | 29 | 0.100 |
Why?
|
| Activities of Daily Living | 1 | 2014 | 301 | 0.100 |
Why?
|
| MicroRNAs | 1 | 2018 | 617 | 0.100 |
Why?
|
| Health Literacy | 1 | 2012 | 77 | 0.100 |
Why?
|
| Population Surveillance | 2 | 2010 | 206 | 0.090 |
Why?
|
| Animals, Genetically Modified | 3 | 2018 | 281 | 0.090 |
Why?
|
| Fasciitis | 1 | 1991 | 2 | 0.090 |
Why?
|
| Risk-Taking | 4 | 2016 | 159 | 0.090 |
Why?
|
| Preventive Medicine | 1 | 1991 | 25 | 0.090 |
Why?
|
| Efficiency, Organizational | 1 | 2012 | 95 | 0.090 |
Why?
|
| Cone-Beam Computed Tomography | 1 | 2011 | 71 | 0.090 |
Why?
|
| Consensus | 3 | 2019 | 199 | 0.090 |
Why?
|
| Biomarkers, Tumor | 1 | 2014 | 466 | 0.090 |
Why?
|
| Health Services Research | 1 | 2012 | 270 | 0.090 |
Why?
|
| Thoracic Arteries | 1 | 1990 | 3 | 0.090 |
Why?
|
| Activating Transcription Factors | 1 | 2010 | 10 | 0.090 |
Why?
|
| Mammary Arteries | 1 | 1990 | 11 | 0.090 |
Why?
|
| Cyclic AMP Response Element-Binding Protein | 1 | 2010 | 44 | 0.090 |
Why?
|
| Mediastinum | 1 | 1990 | 25 | 0.090 |
Why?
|
| Immobilization | 1 | 2010 | 12 | 0.090 |
Why?
|
| Amyloid Precursor Protein Secretases | 1 | 2010 | 67 | 0.090 |
Why?
|
| Breast | 1 | 2012 | 173 | 0.090 |
Why?
|
| Behavioral Risk Factor Surveillance System | 2 | 2008 | 48 | 0.090 |
Why?
|
| Hematopoietic Stem Cell Transplantation | 1 | 2013 | 329 | 0.090 |
Why?
|
| Communications Media | 1 | 2009 | 2 | 0.080 |
Why?
|
| Tumor Burden | 1 | 2010 | 62 | 0.080 |
Why?
|
| Proto-Oncogene Proteins c-bcl-2 | 1 | 2010 | 98 | 0.080 |
Why?
|
| Arm | 1 | 1990 | 38 | 0.080 |
Why?
|
| Computer Communication Networks | 2 | 2008 | 13 | 0.080 |
Why?
|
| Patient Positioning | 1 | 2010 | 43 | 0.080 |
Why?
|
| Aneurysm | 1 | 1990 | 54 | 0.080 |
Why?
|
| Human papillomavirus 6 | 1 | 2009 | 4 | 0.080 |
Why?
|
| Condylomata Acuminata | 1 | 2009 | 9 | 0.080 |
Why?
|
| Colonography, Computed Tomographic | 1 | 2009 | 20 | 0.080 |
Why?
|
| Follow-Up Studies | 2 | 2019 | 2360 | 0.080 |
Why?
|
| Histological Techniques | 1 | 1989 | 18 | 0.080 |
Why?
|
| Retrospective Studies | 8 | 2014 | 6147 | 0.080 |
Why?
|
| Genital Neoplasms, Female | 1 | 2009 | 19 | 0.080 |
Why?
|
| Program Evaluation | 2 | 2008 | 488 | 0.080 |
Why?
|
| Animals | 9 | 2021 | 19739 | 0.080 |
Why?
|
| Regression Analysis | 2 | 2011 | 483 | 0.080 |
Why?
|
| Mental Health | 1 | 2012 | 349 | 0.080 |
Why?
|
| Sex Distribution | 4 | 2011 | 255 | 0.080 |
Why?
|
| Linear Models | 2 | 2009 | 423 | 0.080 |
Why?
|
| Insurance, Health | 1 | 2010 | 143 | 0.080 |
Why?
|
| Analysis of Variance | 2 | 2009 | 576 | 0.080 |
Why?
|
| Chi-Square Distribution | 1 | 2009 | 406 | 0.080 |
Why?
|
| Diagnostic Errors | 1 | 1989 | 98 | 0.080 |
Why?
|
| Drug Delivery Systems | 1 | 2011 | 311 | 0.080 |
Why?
|
| Mental Processes | 1 | 2008 | 18 | 0.070 |
Why?
|
| Sick Role | 1 | 2007 | 15 | 0.070 |
Why?
|
| Puerto Rico | 3 | 2014 | 233 | 0.070 |
Why?
|
| Brain | 2 | 2015 | 1485 | 0.070 |
Why?
|
| Algorithms | 2 | 2010 | 1006 | 0.070 |
Why?
|
| Genome, Viral | 2 | 2018 | 122 | 0.070 |
Why?
|
| Ganglionic Stimulants | 1 | 2007 | 5 | 0.070 |
Why?
|
| Disruptive, Impulse Control, and Conduct Disorders | 1 | 2007 | 8 | 0.070 |
Why?
|
| Cotinine | 1 | 2007 | 18 | 0.070 |
Why?
|
| Friends | 1 | 2007 | 29 | 0.070 |
Why?
|
| Antineoplastic Combined Chemotherapy Protocols | 1 | 2010 | 406 | 0.070 |
Why?
|
| Cosmetic Techniques | 1 | 2006 | 8 | 0.070 |
Why?
|
| Cosmetics | 1 | 2006 | 17 | 0.070 |
Why?
|
| Gene Expression Profiling | 1 | 2010 | 713 | 0.070 |
Why?
|
| Women's Health | 1 | 2009 | 390 | 0.070 |
Why?
|
| Testicular Neoplasms | 1 | 2006 | 32 | 0.070 |
Why?
|
| RNA, Messenger | 3 | 2019 | 1465 | 0.070 |
Why?
|
| Skin Pigmentation | 1 | 2006 | 32 | 0.070 |
Why?
|
| Attention | 1 | 2008 | 151 | 0.070 |
Why?
|
| Depression | 2 | 2016 | 868 | 0.060 |
Why?
|
| Social Perception | 1 | 2006 | 36 | 0.060 |
Why?
|
| Sheep, Domestic | 2 | 2018 | 13 | 0.060 |
Why?
|
| Physician's Role | 1 | 2007 | 120 | 0.060 |
Why?
|
| Genetic Testing | 1 | 2006 | 131 | 0.060 |
Why?
|
| Overweight | 1 | 2008 | 249 | 0.060 |
Why?
|
| Nicotine | 1 | 2007 | 111 | 0.060 |
Why?
|
| Substance Withdrawal Syndrome | 1 | 2007 | 119 | 0.060 |
Why?
|
| Confidence Intervals | 3 | 2011 | 257 | 0.060 |
Why?
|
| Infant | 5 | 2013 | 1522 | 0.060 |
Why?
|
| Neoplasm Grading | 2 | 2015 | 76 | 0.060 |
Why?
|
| Respiration Disorders | 1 | 2005 | 21 | 0.060 |
Why?
|
| Marijuana Smoking | 1 | 2005 | 16 | 0.060 |
Why?
|
| Bone and Bones | 3 | 1992 | 156 | 0.060 |
Why?
|
| Incidence | 2 | 2024 | 1267 | 0.060 |
Why?
|
| Pilot Projects | 2 | 2024 | 930 | 0.060 |
Why?
|
| Evaluation Studies as Topic | 1 | 2004 | 104 | 0.060 |
Why?
|
| Sunscreening Agents | 3 | 2009 | 21 | 0.060 |
Why?
|
| Food | 2 | 2015 | 80 | 0.060 |
Why?
|
| State Government | 2 | 2014 | 32 | 0.060 |
Why?
|
| World Health Organization | 1 | 2024 | 30 | 0.060 |
Why?
|
| Food, Fortified | 1 | 2024 | 21 | 0.060 |
Why?
|
| Religion | 1 | 2004 | 33 | 0.060 |
Why?
|
| Fear | 1 | 2004 | 67 | 0.050 |
Why?
|
| Qualitative Research | 3 | 2013 | 633 | 0.050 |
Why?
|
| Suicide | 1 | 2004 | 124 | 0.050 |
Why?
|
| Cohort Studies | 2 | 2019 | 2480 | 0.050 |
Why?
|
| Drug Administration Routes | 1 | 2021 | 20 | 0.050 |
Why?
|
| Neuroticism | 1 | 2021 | 2 | 0.050 |
Why?
|
| Commerce | 1 | 2022 | 59 | 0.050 |
Why?
|
| Policy | 1 | 2022 | 48 | 0.050 |
Why?
|
| Radius | 2 | 1992 | 13 | 0.050 |
Why?
|
| Arthritis, Infectious | 2 | 1991 | 19 | 0.050 |
Why?
|
| Hazardous Substances | 1 | 2001 | 16 | 0.050 |
Why?
|
| Humerus | 2 | 1992 | 9 | 0.050 |
Why?
|
| Anticonvulsants | 1 | 2022 | 95 | 0.050 |
Why?
|
| Civil Defense | 1 | 2001 | 12 | 0.050 |
Why?
|
| Prospective Studies | 2 | 2019 | 3133 | 0.050 |
Why?
|
| Disease Outbreaks | 1 | 2001 | 104 | 0.040 |
Why?
|
| Acquired Immunodeficiency Syndrome | 2 | 1991 | 137 | 0.040 |
Why?
|
| Culture | 2 | 2013 | 76 | 0.040 |
Why?
|
| Communicable Diseases | 1 | 2001 | 83 | 0.040 |
Why?
|
| Health Policy | 1 | 2022 | 183 | 0.040 |
Why?
|
| Fibrous Dysplasia of Bone | 2 | 1990 | 5 | 0.040 |
Why?
|
| Mutation | 2 | 2019 | 2466 | 0.040 |
Why?
|
| Patella | 2 | 1990 | 13 | 0.040 |
Why?
|
| Tumor Cells, Cultured | 2 | 2010 | 453 | 0.040 |
Why?
|
| Mice | 4 | 2019 | 10317 | 0.040 |
Why?
|
| Biopsy | 3 | 2015 | 375 | 0.040 |
Why?
|
| Residence Characteristics | 2 | 2012 | 230 | 0.040 |
Why?
|
| Cell Phone | 1 | 2019 | 43 | 0.040 |
Why?
|
| Neoplasm Recurrence, Local | 2 | 2010 | 302 | 0.040 |
Why?
|
| History, 21st Century | 1 | 2019 | 166 | 0.040 |
Why?
|
| Mobile Applications | 1 | 2020 | 130 | 0.040 |
Why?
|
| Wool | 1 | 2018 | 5 | 0.040 |
Why?
|
| Electrolytes | 1 | 2018 | 24 | 0.040 |
Why?
|
| Internal Capsule | 1 | 2018 | 12 | 0.040 |
Why?
|
| Immunoassay | 1 | 2018 | 52 | 0.040 |
Why?
|
| Serogroup | 1 | 2018 | 32 | 0.040 |
Why?
|
| Injections | 1 | 2018 | 79 | 0.040 |
Why?
|
| Demography | 2 | 2010 | 178 | 0.040 |
Why?
|
| Emergency Medical Services | 1 | 2001 | 251 | 0.040 |
Why?
|
| Capacity Building | 1 | 2017 | 22 | 0.040 |
Why?
|
| Case-Control Studies | 2 | 2009 | 1064 | 0.040 |
Why?
|
| Radionuclide Imaging | 2 | 2015 | 116 | 0.040 |
Why?
|
| Dietary Sucrose | 1 | 2017 | 30 | 0.030 |
Why?
|
| Cell Line, Tumor | 2 | 2010 | 1387 | 0.030 |
Why?
|
| Green Fluorescent Proteins | 1 | 2018 | 354 | 0.030 |
Why?
|
| Risk Reduction Behavior | 1 | 2017 | 125 | 0.030 |
Why?
|
| United States Food and Drug Administration | 1 | 2016 | 95 | 0.030 |
Why?
|
| Patient Preference | 1 | 2016 | 77 | 0.030 |
Why?
|
| Semantics | 1 | 2016 | 58 | 0.030 |
Why?
|
| Joint Diseases | 1 | 1995 | 18 | 0.030 |
Why?
|
| Kidney | 1 | 2018 | 397 | 0.030 |
Why?
|
| Referral and Consultation | 1 | 2019 | 409 | 0.030 |
Why?
|
| Cost of Illness | 1 | 2016 | 157 | 0.030 |
Why?
|
| Lipoma | 2 | 1995 | 18 | 0.030 |
Why?
|
| Epidemiologic Methods | 1 | 2015 | 69 | 0.030 |
Why?
|
| Pituitary Neoplasms | 1 | 2015 | 24 | 0.030 |
Why?
|
| Feasibility Studies | 1 | 2017 | 531 | 0.030 |
Why?
|
| Faculty, Medical | 1 | 2017 | 203 | 0.030 |
Why?
|
| Microglia | 1 | 2018 | 229 | 0.030 |
Why?
|
| Societies, Medical | 1 | 2017 | 342 | 0.030 |
Why?
|
| Shoulder | 2 | 1992 | 23 | 0.030 |
Why?
|
| Sampling Studies | 2 | 1991 | 66 | 0.030 |
Why?
|
| Lymphedema | 1 | 2014 | 7 | 0.030 |
Why?
|
| Neoplasm Metastasis | 1 | 2015 | 196 | 0.030 |
Why?
|
| Diagnostic Imaging | 2 | 1994 | 242 | 0.030 |
Why?
|
| Waist Circumference | 1 | 2014 | 53 | 0.030 |
Why?
|
| Postmenopause | 1 | 2015 | 246 | 0.030 |
Why?
|
| Optical Imaging | 1 | 2015 | 68 | 0.030 |
Why?
|
| Child Behavior | 1 | 2014 | 68 | 0.030 |
Why?
|
| Hotlines | 1 | 2013 | 22 | 0.030 |
Why?
|
| Gender Identity | 1 | 2014 | 61 | 0.030 |
Why?
|
| Computer Security | 1 | 2013 | 12 | 0.030 |
Why?
|
| Extremities | 2 | 1991 | 50 | 0.030 |
Why?
|
| Statistics as Topic | 1 | 2014 | 146 | 0.030 |
Why?
|
| Treatment Outcome | 2 | 2017 | 5266 | 0.030 |
Why?
|
| Liver | 1 | 2018 | 785 | 0.030 |
Why?
|
| Fatigue | 1 | 2014 | 104 | 0.030 |
Why?
|
| Health Status Disparities | 1 | 2015 | 146 | 0.030 |
Why?
|
| Internal-External Control | 1 | 2013 | 32 | 0.030 |
Why?
|
| Fluorescent Dyes | 1 | 2015 | 197 | 0.030 |
Why?
|
| Chondroblastoma | 2 | 1993 | 2 | 0.030 |
Why?
|
| C-Reactive Protein | 1 | 2014 | 168 | 0.030 |
Why?
|
| Exercise Therapy | 1 | 2014 | 102 | 0.030 |
Why?
|
| Geographic Information Systems | 1 | 2013 | 21 | 0.030 |
Why?
|
| Curriculum | 1 | 2017 | 569 | 0.030 |
Why?
|
| Software | 1 | 2016 | 376 | 0.030 |
Why?
|
| Stereotaxic Techniques | 1 | 2013 | 29 | 0.030 |
Why?
|
| Cholesterol | 1 | 2014 | 255 | 0.030 |
Why?
|
| Myxoma | 2 | 1989 | 14 | 0.030 |
Why?
|
| Canada | 1 | 2013 | 149 | 0.030 |
Why?
|
| Family Characteristics | 1 | 2012 | 44 | 0.030 |
Why?
|
| Adolescent Behavior | 1 | 2014 | 189 | 0.030 |
Why?
|
| Body Weight | 1 | 2014 | 381 | 0.030 |
Why?
|
| Triglycerides | 1 | 2014 | 242 | 0.030 |
Why?
|
| Metacarpus | 1 | 1992 | 1 | 0.030 |
Why?
|
| Metatarsus | 1 | 1992 | 1 | 0.030 |
Why?
|
| Predictive Value of Tests | 1 | 2015 | 1037 | 0.030 |
Why?
|
| Ulna | 1 | 1992 | 4 | 0.030 |
Why?
|
| Fibula | 1 | 1992 | 9 | 0.030 |
Why?
|
| Geography | 1 | 2012 | 32 | 0.030 |
Why?
|
| Utah | 1 | 1992 | 7 | 0.020 |
Why?
|
| Fingers | 1 | 1992 | 42 | 0.020 |
Why?
|
| Sarcoma, Synovial | 1 | 1992 | 6 | 0.020 |
Why?
|
| Tea | 1 | 1992 | 26 | 0.020 |
Why?
|
| Seat Belts | 1 | 1991 | 11 | 0.020 |
Why?
|
| Fluoroscopy | 1 | 2011 | 62 | 0.020 |
Why?
|
| Pelvic Bones | 1 | 1991 | 14 | 0.020 |
Why?
|
| Sunlight | 1 | 1991 | 29 | 0.020 |
Why?
|
| Preconception Care | 1 | 1991 | 24 | 0.020 |
Why?
|
| Hip Joint | 1 | 1991 | 35 | 0.020 |
Why?
|
| Bone Cysts | 2 | 1989 | 6 | 0.020 |
Why?
|
| Lymphoma, Large B-Cell, Diffuse | 1 | 1992 | 65 | 0.020 |
Why?
|
| Blood-Brain Barrier | 1 | 2011 | 81 | 0.020 |
Why?
|
| Healthcare Disparities | 1 | 2015 | 332 | 0.020 |
Why?
|
| Forearm | 1 | 1991 | 19 | 0.020 |
Why?
|
| Sensitivity and Specificity | 1 | 2014 | 1100 | 0.020 |
Why?
|
| Mycobacterium avium-intracellulare Infection | 1 | 1991 | 8 | 0.020 |
Why?
|
| Wrist Joint | 1 | 1991 | 8 | 0.020 |
Why?
|
| Rectum | 1 | 1991 | 85 | 0.020 |
Why?
|
| Energy Intake | 1 | 2012 | 213 | 0.020 |
Why?
|
| Gadolinium | 1 | 2011 | 102 | 0.020 |
Why?
|
| Carmustine | 1 | 2010 | 10 | 0.020 |
Why?
|
| Spinal Neoplasms | 1 | 1990 | 15 | 0.020 |
Why?
|
| Sexually Transmitted Diseases | 1 | 1991 | 94 | 0.020 |
Why?
|
| Actigraphy | 1 | 2011 | 47 | 0.020 |
Why?
|
| Spheroids, Cellular | 1 | 2010 | 26 | 0.020 |
Why?
|
| DNA, Complementary | 1 | 2010 | 162 | 0.020 |
Why?
|
| Benzenesulfonates | 1 | 2010 | 14 | 0.020 |
Why?
|
| Myeloid Cell Leukemia Sequence 1 Protein | 1 | 2010 | 19 | 0.020 |
Why?
|
| Niacinamide | 1 | 2010 | 32 | 0.020 |
Why?
|
| Dipeptides | 1 | 2010 | 61 | 0.020 |
Why?
|
| Phenylurea Compounds | 1 | 2010 | 30 | 0.020 |
Why?
|
| Mice, Nude | 1 | 2010 | 260 | 0.020 |
Why?
|
| Cell Adhesion | 1 | 2010 | 208 | 0.020 |
Why?
|
| Signal Transduction | 2 | 2010 | 2892 | 0.020 |
Why?
|
| Osteitis Deformans | 1 | 1990 | 2 | 0.020 |
Why?
|
| Fractures, Bone | 1 | 1991 | 150 | 0.020 |
Why?
|
| Transplantation, Heterologous | 1 | 2010 | 225 | 0.020 |
Why?
|
| DNA Primers | 1 | 2010 | 290 | 0.020 |
Why?
|
| Insulin | 1 | 2014 | 692 | 0.020 |
Why?
|
| Neoplasm Transplantation | 1 | 2010 | 160 | 0.020 |
Why?
|
| Social Change | 1 | 2009 | 13 | 0.020 |
Why?
|
| Xenograft Model Antitumor Assays | 1 | 2010 | 183 | 0.020 |
Why?
|
| Online Systems | 1 | 2009 | 21 | 0.020 |
Why?
|
| Receptors, Notch | 1 | 2010 | 100 | 0.020 |
Why?
|
| Blogging | 1 | 2009 | 10 | 0.020 |
Why?
|
| Exons | 1 | 2010 | 190 | 0.020 |
Why?
|
| Bone Diseases | 1 | 1990 | 21 | 0.020 |
Why?
|
| Occult Blood | 1 | 2009 | 16 | 0.020 |
Why?
|
| Radiographic Image Enhancement | 1 | 1990 | 98 | 0.020 |
Why?
|
| Electronic Mail | 1 | 2010 | 46 | 0.020 |
Why?
|
| Pyridines | 1 | 2010 | 98 | 0.020 |
Why?
|
| Internship and Residency | 1 | 2017 | 748 | 0.020 |
Why?
|
| Nutrition Assessment | 1 | 2009 | 58 | 0.020 |
Why?
|
| Cell Culture Techniques | 1 | 2010 | 179 | 0.020 |
Why?
|
| Practice Guidelines as Topic | 1 | 2013 | 713 | 0.020 |
Why?
|
| Evidence-Based Practice | 1 | 2010 | 82 | 0.020 |
Why?
|
| Cell Death | 1 | 2010 | 272 | 0.020 |
Why?
|
| Cell Division | 1 | 2010 | 442 | 0.020 |
Why?
|
| Telephone | 1 | 2009 | 121 | 0.020 |
Why?
|
| Health Services | 1 | 2009 | 85 | 0.020 |
Why?
|
| Colonoscopy | 1 | 2009 | 104 | 0.020 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2010 | 525 | 0.020 |
Why?
|
| Institutional Management Teams | 1 | 2008 | 3 | 0.020 |
Why?
|
| Time Management | 1 | 2008 | 9 | 0.020 |
Why?
|
| Empirical Research | 1 | 2008 | 14 | 0.020 |
Why?
|
| Creativity | 1 | 2008 | 13 | 0.020 |
Why?
|
| Muscles | 1 | 1989 | 172 | 0.020 |
Why?
|
| Censuses | 1 | 2008 | 15 | 0.020 |
Why?
|
| Income | 1 | 2009 | 162 | 0.020 |
Why?
|
| Social Class | 1 | 2009 | 126 | 0.020 |
Why?
|
| Models, Psychological | 1 | 2008 | 93 | 0.020 |
Why?
|
| Individuality | 1 | 2008 | 21 | 0.020 |
Why?
|
| SEER Program | 1 | 2008 | 68 | 0.020 |
Why?
|
| Attitude | 1 | 2008 | 101 | 0.020 |
Why?
|
| Organizational Innovation | 1 | 2008 | 84 | 0.020 |
Why?
|
| Mental Recall | 1 | 2008 | 94 | 0.020 |
Why?
|
| Interprofessional Relations | 1 | 2008 | 134 | 0.020 |
Why?
|
| Administration, Intranasal | 1 | 2007 | 28 | 0.020 |
Why?
|
| Patient Compliance | 1 | 2009 | 373 | 0.020 |
Why?
|
| Self-Help Groups | 1 | 2007 | 37 | 0.020 |
Why?
|
| Mammography | 1 | 2009 | 273 | 0.020 |
Why?
|
| RNA Interference | 1 | 2010 | 592 | 0.020 |
Why?
|
| Beauty Culture | 1 | 2006 | 16 | 0.020 |
Why?
|
| Protective Clothing | 1 | 2006 | 29 | 0.020 |
Why?
|
| Radiation Protection | 1 | 2006 | 25 | 0.020 |
Why?
|
| Evidence-Based Medicine | 1 | 2009 | 457 | 0.020 |
Why?
|
| Drug Administration Schedule | 1 | 2007 | 281 | 0.020 |
Why?
|
| Prognosis | 1 | 2010 | 1591 | 0.020 |
Why?
|
| Sunburn | 1 | 2006 | 11 | 0.020 |
Why?
|
| Antineoplastic Agents | 1 | 2010 | 646 | 0.020 |
Why?
|
| Adaptation, Psychological | 1 | 2007 | 264 | 0.020 |
Why?
|
| Respiratory Sounds | 1 | 2005 | 20 | 0.010 |
Why?
|
| Research Design | 1 | 2008 | 569 | 0.010 |
Why?
|
| Apoptosis | 1 | 2010 | 1042 | 0.010 |
Why?
|
| Spirometry | 1 | 2005 | 94 | 0.010 |
Why?
|
| Dyspnea | 1 | 2005 | 110 | 0.010 |
Why?
|
| Massachusetts | 1 | 2010 | 2119 | 0.010 |
Why?
|
| Mice, Inbred C57BL | 1 | 2010 | 3215 | 0.010 |
Why?
|
| Cough | 1 | 2005 | 183 | 0.010 |
Why?
|
| Hospitalization | 1 | 2010 | 1304 | 0.010 |
Why?
|
| Liposarcoma | 2 | 1991 | 9 | 0.010 |
Why?
|
| Synovial Cyst | 1 | 1995 | 1 | 0.010 |
Why?
|
| Cartilage, Articular | 1 | 1995 | 74 | 0.010 |
Why?
|
| Preoperative Care | 1 | 1995 | 177 | 0.010 |
Why?
|
| Neoplasm Staging | 1 | 1995 | 460 | 0.010 |
Why?
|
| Image Enhancement | 1 | 1995 | 191 | 0.010 |
Why?
|
| Osteochondroma | 1 | 1993 | 3 | 0.010 |
Why?
|
| Chondroma | 1 | 1993 | 3 | 0.010 |
Why?
|
| Diatrizoate Meglumine | 1 | 1991 | 5 | 0.010 |
Why?
|
| Extravasation of Diagnostic and Therapeutic Materials | 1 | 1991 | 16 | 0.010 |
Why?
|
| Enema | 1 | 1991 | 12 | 0.010 |
Why?
|
| Medical History Taking | 1 | 1991 | 59 | 0.010 |
Why?
|
| Substance Abuse, Intravenous | 1 | 1991 | 75 | 0.010 |
Why?
|
| Back Pain | 1 | 1990 | 51 | 0.010 |
Why?
|
| Histiocytoma, Benign Fibrous | 1 | 1990 | 1 | 0.010 |
Why?
|
| Lipomatosis | 1 | 1990 | 8 | 0.010 |
Why?
|
| Alkaline Phosphatase | 1 | 1990 | 42 | 0.010 |
Why?
|
| Neurofibroma | 1 | 1989 | 2 | 0.010 |
Why?
|
| Synovitis, Pigmented Villonodular | 1 | 1989 | 3 | 0.010 |
Why?
|
| Epidermal Cyst | 1 | 1989 | 10 | 0.010 |
Why?
|
| Angiography | 1 | 1990 | 145 | 0.010 |
Why?
|
| Nervous System Diseases | 1 | 1990 | 104 | 0.000 |
Why?
|
| Abscess | 1 | 1989 | 75 | 0.000 |
Why?
|
| Staphylococcal Infections | 1 | 1989 | 116 | 0.000 |
Why?
|